Showing results (121-130 of 369) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancerMatthew D Galsky, Mario Eisenberger, Sandra Moore-Cooper, et al.Journal of Neuro-Oncology|November 20, 2008
A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM)Teri N Kreisl, Andrew B Lassman, Paul S Mischel, et al.Psychology and Aging|May 25, 2011
Models of self and others and their relation to positive and negative caregiving responsesJennifer Q Morse, David R Shaffer, Gail M Williamson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Prognostic value of baseline [18F] fluorodeoxyglucose positron emission tomography and 99mTc-MDP bone scan in progressing metastatic prostate cancerGustavo S P Meirelles, Heiko Schöder, Gregory C Ravizzini, et al.Cancer|October 30, 2003
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinomaDavid B Solit, Michael Morris, Susan Slovin, et al.Cancer Chemotherapy and Pharmacology|March 11, 2010
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancerDana Rathkopf, Bryan Y Wong, Robert W Ross, et al.European Urology|August 20, 2013
Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survivalDaniel C Danila, Aseem Anand, Nikolaus Schultz, et al.International Journal of Cancer|April 1, 2005
Induction of autoantibodies to syngeneic prostate-specific membrane antigen by xenogeneic vaccinationPolly D Gregor, Jedd D Wolchok, Vandana Turaga, et al.Cancer Research|September 14, 2012
Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumorsNicholas Mitsiades, Clifford C Sung, Nikolaus Schultz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2013
Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trialCharles J Ryan, Arturo Molina, Jinhui Li, et al.Pageof 37